We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$2.9B
AUM Growth
-$1.19B
Cap. Flow
-$1.27B
Cap. Flow %
-43.75%
Top 10 Hldgs %
34.83%
Holding
644
New
132
Increased
85
Reduced
129
Closed
248

Sector Composition

Rank Sector Weight
1 Financials 21.26%
2 Real Estate 14.1%
3 Healthcare 6.11%
4 Industrials 4.83%
5 Technology 4.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEGR
351
DELISTED
Aegerion Pharmaceuticals
AEGR
$419K 0.01%
20,000
-10,000
-33% -$252K
USO icon
352
United States Oil Fund
USO
$2.45B
$407K 0.01%
+2,500
New +$554K
CNCE
353
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$386K 0.01%
29,000
-1,000
-3% -$12.9K
ENTR
354
DELISTED
ENTROPIC COMMUNICATIONS INC COM STK (DE)
ENTR
$380K 0.01%
150,000
-170,000
-53% -$413K
ARWR icon
355
Arrowhead Research
ARWR
$12.1B
$369K 0.01%
50,000
-10,000
-17% -$68K
CRIS icon
356
Curis
CRIS
$9.53M
$368K 0.01%
123
SRPT icon
357
Sarepta Therapeutics
SRPT
$1.66B
$362K 0.01%
25,000
+15,000
+150% +$254K
KBIO
358
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$346K 0.01%
25,000
ANTH
359
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$332K 0.01%
26,250
NM
360
CALL
DELISTED
Navios Maritime Holdings Inc.
NM
$329K 0.01%
8,000
+590
+8% +$29.5K
STAA icon
361
STAAR Surgical
STAA
$1.16B
$319K 0.01%
35,000
+10,000
+40% +$96.8K
IONS icon
362
CALL
Ionis Pharmaceuticals
IONS
$9.35B
$309K 0.01%
5,000
-5,000
-50% -$247K
MDR
363
CALL
DELISTED
McDermott International
MDR
$291K 0.01%
33,333
KERX
364
CALL
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$283K 0.01%
+20,000
New +$310K
OPCH icon
365
Option Care Health
OPCH
$3.4B
$280K 0.01%
10,000
SKIS
366
DELISTED
Peak Resorts, Inc.
SKIS
$280K 0.01%
+35,000
New +$280K
LITS
367
Lite Strategy Inc
LITS
$33.6M
$278K 0.01%
3,250
SQNM
368
DELISTED
SEQUENOM INC NEW
SQNM
$278K 0.01%
75,000
-25,000
-25% -$81K
BALT
369
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
$272K 0.01%
+108,324
New +$346K
ROKA
370
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$269K 0.01%
+6,100
New +$386K
MOH icon
371
Molina Healthcare
MOH
$10.3B
$268K 0.01%
+5,000
New +$242K
MPG
372
DELISTED
Metaldyne Performance Group Inc.
MPG
$260K 0.01%
+15,000
New +$236K
ACHN
373
PUT
DELISTED
Achillion Pharmaceuticals
ACHN
$245K 0.01%
+20,000
New +$244K
VXX
374
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$236K 0.01%
468
NBIX icon
375
Neurocrine Biosciences
NBIX
$17.7B
$223K 0.01%
10,000
-10,000
-50% -$189K

Similar funds

Weiss Multi-Strategy Advisers's Q4 2014 Portfolio in Review

As of Q4 2014, Weiss Multi-Strategy Advisers held 644 positions worth $2.9B, down 29% from $4.09B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Weiss Multi-Strategy Advisers withdrew a net $1.27B in Q4 2014, closing 248 positions and reducing 129 holdings. Its most notable exit was Coca-Cola Europacific Partners, an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 12% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Weiss Multi-Strategy Advisers opened a new position in Capital One worth $45.4M.

  • Weiss Multi-Strategy Advisers's largest Q4 2014 buy was Capital One: 550,000 shares worth $45.4M.
  • Weiss Multi-Strategy Advisers added most to Prologis in Q4 2014, an estimated $36.2M increase.
  • Weiss Multi-Strategy Advisers's biggest Q4 2014 reduction was Synovus, cutting an estimated $27.8M.
  • Weiss Multi-Strategy Advisers fully exited Coca-Cola Europacific Partners in Q4 2014, selling an estimated $25.2M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 35% of its $2.9B portfolio in Q4 2014.
  • Weiss Multi-Strategy Advisers opened 132 new positions and closed 248 in Q4 2014.
  • Weiss Multi-Strategy Advisers's portfolio value fell 29% quarter-over-quarter to $2.9B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2014, filed 17 Feb 2015.